Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge.
Lacroix C, Salvo F, Gras-Champel V, Gautier S, Massy N, Valnet-Rabier MB, Grandvuillemin A, Mounier C, Benkebil M, Pariente A, Jonville-Béra AP, Micallef J; French Network of Pharmacovigilance Centres. Lacroix C, et al. Among authors: salvo f. Therapie. 2021 Jul-Aug;76(4):297-303. doi: 10.1016/j.therap.2021.05.003. Epub 2021 May 7. Therapie. 2021. PMID: 34059351 Free PMC article.
Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres.
Gras-Champel V, Liabeuf S, Baud M, Albucher JF, Benkebil M, Boulay C, Bron A, El Kaddissi A, Gautier S, Geeraerts T, Girot M, Grandvuillemin A, Laujin H, Jonville-Béra AP, Masmoudi K, Massardier E, Micallef J, Mounier C, Montastruc F, Pariente A, Perez J, Raposo N, Salvo F, Valnet-Rabier MB, Vial T, Massy N; French Network of Pharmacovigilance Centres. Gras-Champel V, et al. Among authors: salvo f. Therapie. 2021 Jul-Aug;76(4):369-373. doi: 10.1016/j.therap.2021.05.007. Epub 2021 May 19. Therapie. 2021. PMID: 34083026 Free PMC article. No abstract available.
De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring.
Moulis G, Crickx E, Thomas L, Massy N, Mahévas M, Valnet-Rabier MB, Atzenhoffer M, Michel M, Godeau B, Bagheri H, Salvo F; French Covigilance COVID-19 Vaccine-ITP Study Group. Moulis G, et al. Among authors: salvo f. Blood. 2022 Apr 21;139(16):2561-2565. doi: 10.1182/blood.2022015470. Blood. 2022. PMID: 35446373 Free PMC article. No abstract available.
Correction to "Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study".
Ouldali N, Bagheri H, Salvo F, Antona D, Pariente A, Leblanc C, Tebacher M, Micallef J, Levy C, Cohen R, Javouhey E, Bader-Meunier B, Ovaert C, Renolleau S, Hentgen V, Kone-Paut I, Deschamps N, De Pontual L, Iriart X, Guen CG, Angoulvant F, Belot A; French Covid-19 Paediatric Inflammation Consortium; French Pharmacovigilance network. Ouldali N, et al. Among authors: salvo f. Lancet Reg Health Eur. 2022 Oct;21:100468. doi: 10.1016/j.lanepe.2022.100468. Epub 2022 Aug 10. Lancet Reg Health Eur. 2022. PMID: 35967266 Free PMC article.
Antipsychotics and risk of QT prolongation: a pharmacovigilance study.
Bordet C, Garcia P, Salvo F, Touafchia A, Galinier M, Sommet A, Montastruc F. Bordet C, et al. Among authors: salvo f. Psychopharmacology (Berl). 2023 Jan;240(1):199-202. doi: 10.1007/s00213-022-06293-4. Epub 2022 Dec 14. Psychopharmacology (Berl). 2023. PMID: 36515735
266 results